Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma ; volume:22 ; number:1 ; day:31 ; month:10 ; year:2022 ; pages:1-9 ; date:12.2022
BMC gastroenterology ; 22, Heft 1 (31.10.2022), 1-9, 12.2022
- Urheber
-
Gu, Xiaoying
Zhang, Su
Yang, Xuejiao
Guan, Tao
Hou, Zhenyu
Cao, Manqing
Li, Huikai
Zhang, Ti
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02542-0
- URN
-
urn:nbn:de:101:1-2023011509015934896279
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gu, Xiaoying
- Zhang, Su
- Yang, Xuejiao
- Guan, Tao
- Hou, Zhenyu
- Cao, Manqing
- Li, Huikai
- Zhang, Ti
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Drug-related crime
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
Rhabdomyolysis in drug-related deaths
Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Drug-related crime
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
Rhabdomyolysis in drug-related deaths
Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Drug-related crime
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
Rhabdomyolysis in drug-related deaths